CYCLACEL
In a transaction thought to be the largest biotech funding in UK history, KLegal acted for Cyclacel to raise £34m. The team advising the Scottish-based cancer therapeutics company was led by Patrick Martin. The funding involved the subscription for preferred shares by a syndicate of investors led by Invesco Private Capital and included investors such […]